Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
The New England journal of medicine, 2021-04, Vol.384 (14), p.1289-1300 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035716 ;PMID: 33616314
Full text available